Results 111 to 120 of about 1,659,809 (298)

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

open access: yesArthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner   +14 more
wiley   +1 more source

Cognitive Behavioral Therapy for Youth with Childhood‐Onset Lupus: A Randomized Clinical Trial

open access: yesArthritis Care &Research, Accepted Article.
Objective Our objective was to determine the feasibility and acceptability of the Treatment and Education Approach for Childhood‐onset Lupus (TEACH), a six‐session cognitive behavioral intervention addressing depressive, fatigue, and pain symptoms, delivered remotely to individual youth with lupus by a trained interventionist.
Natoshia R. Cunningham   +29 more
wiley   +1 more source

Agomelatine as monotherapy for major depression: an outpatient, open-label study [Corrigendum]

open access: yesNeuropsychiatric Disease and Treatment, 2013
Pecenak J, Novotny V. Neuropsychiatric Disease and Treatment 2013;9:1595–1604.On page 1601, line 1 in the right-hand column, note that the drug "venlafaxine" is incorrect and should instead be "fluoxetine".
Pecenak J, Novotny V
doaj  

Practice Matters: Screening and Referring Congregants with Major Depression [PDF]

open access: yes, 2015
The purpose of this article is to provide Faith Community Nurses with current recommendations regarding screening and caring for individuals with major depression.
Branstetter, Mary, DNP   +2 more
core   +1 more source

Differential Item Functioning on the Patient Health Questionnaire‐8 by Disease Subtype, Language, Sex, and Age among People with Systemic Sclerosis: A Scleroderma Patient‐centered Intervention Network Cohort Study

open access: yesArthritis Care &Research, Accepted Article.
Objective Somatic items used in depression assessments can potentially overlap with symptoms related to physical illness, including systemic sclerosis (SSc). No studies have looked at whether somatic depression items may be influenced by diffuse versus limited SSc disease subtypes, which are associated with varying degrees of symptom presentation.
Sophie Hu   +109 more
wiley   +1 more source

A pilot study differentiating recurrent major depression from bipolar disorder cycling on the depressive pole

open access: yesNeuropsychiatric Disease and Treatment, 2010
Marty Hinz1, Alvin Stein2, Thomas Uncini31Clinical Research, NeuroResearch Clinics, Inc., Cape Coral, FL, USA; 2Stein Orthopedic Associates, Plantation, FL, USA; 3DBS Labs, Duluth, MN, USAPurpose: A novel method for differentiating and treating bipolar ...
Marty Hinz, Alvin Stein, Thomas Uncini
doaj  

A Bayesian Model of Sample Selection with a Discrete Outcome Variable: Detecting Depression in Older Adults [PDF]

open access: yes
Depression as a major mental illness among older adults has attracted a lot of research attention. However, the problem of sample selection, inevitable in most health surveys, has been largely ignored.
Maksym Obrizan
core  

Psychiatric Impact of Tuberous Sclerosis Complex and Utilization of Mental Health Treatment [PDF]

open access: yes, 2018
Tuberous sclerosis complex (TSC) is a multi-system, neurocutaneous disorder with neuropsychiatric features known as TSC-associated neuropsychiatric disorders (TAND).
Mowrey, Kate
core   +1 more source

Use of a Molecular Signature Response Classifier to Inform Treatment Selection Improves Clinical Disease Activity Among Patients with Rheumatoid Arthritis Initiating a Biologic or Targeted Synthetic Disease‐Modifying Antirheumatic Drug

open access: yesArthritis Care &Research, EarlyView.
Objective We assessed the effectiveness of PrismRA to improve clinical outcomes among patients with rheumatoid arthritis (RA) initiating treatment with a biologic or targeted synthetic disease‐modifying antirheumatic drug (b/tsDMARD). Methods PrismRA incorporated 19 gene expression features and four clinical features to assess a patient's likelihood of
Fenglong Xie   +3 more
wiley   +1 more source

Comparing the Efficacy of Fluvoxamine and Sertraline in Treating Major Depressive Disorder (MDD)

open access: yesمجله دانشکده پزشکی اصفهان, 2013
Background: Major depressive disorder (MDD) is a common psychiatric disorder that 16.2 of population in developed countries experience it at least once in their lifetime; it is a major cause of social disability according to WHO reports.
Seyed-Saeid Hasani-Tabatabaei   +3 more
doaj  

Home - About - Disclaimer - Privacy